Although previous studies have reported that PTHrP may not be a useful marker when assessing if cases of PTHrP-related hypercalcemia are malignant or benign [99], these shorter fragments may still possess potential for future biomarker exploration for other pathologies. Here, PTHLH is linked to hypercalcemia disease.